1. Home
  2. NVCR vs COCO Comparison

NVCR vs COCO Comparison

Compare NVCR & COCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • COCO
  • Stock Information
  • Founded
  • NVCR 2000
  • COCO 2004
  • Country
  • NVCR Switzerland
  • COCO United States
  • Employees
  • NVCR N/A
  • COCO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • COCO Beverages (Production/Distribution)
  • Sector
  • NVCR Health Care
  • COCO Consumer Staples
  • Exchange
  • NVCR Nasdaq
  • COCO Nasdaq
  • Market Cap
  • NVCR 1.9B
  • COCO 1.8B
  • IPO Year
  • NVCR 2015
  • COCO 2021
  • Fundamental
  • Price
  • NVCR $16.69
  • COCO $35.12
  • Analyst Decision
  • NVCR Buy
  • COCO Buy
  • Analyst Count
  • NVCR 6
  • COCO 7
  • Target Price
  • NVCR $32.83
  • COCO $36.14
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • COCO 454.4K
  • Earning Date
  • NVCR 07-24-2025
  • COCO 07-30-2025
  • Dividend Yield
  • NVCR N/A
  • COCO N/A
  • EPS Growth
  • NVCR N/A
  • COCO 11.36
  • EPS
  • NVCR N/A
  • COCO 1.01
  • Revenue
  • NVCR $621,711,000.00
  • COCO $535,236,000.00
  • Revenue This Year
  • NVCR $5.56
  • COCO $13.81
  • Revenue Next Year
  • NVCR $9.19
  • COCO $11.17
  • P/E Ratio
  • NVCR N/A
  • COCO $34.86
  • Revenue Growth
  • NVCR 18.27
  • COCO 8.01
  • 52 Week Low
  • NVCR $14.17
  • COCO $23.56
  • 52 Week High
  • NVCR $34.13
  • COCO $40.32
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.44
  • COCO 54.99
  • Support Level
  • NVCR $17.20
  • COCO $32.90
  • Resistance Level
  • NVCR $18.02
  • COCO $33.80
  • Average True Range (ATR)
  • NVCR 1.04
  • COCO 1.02
  • MACD
  • NVCR -0.09
  • COCO 0.01
  • Stochastic Oscillator
  • NVCR 15.51
  • COCO 69.13

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

Share on Social Networks: